Daniel Marsh, MD
Pain Medicine · Boise, IDNPI 1356377535
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 58.4% of the total. Reporting peaked in 2024 at $1,405 and has fallen 71.8% since, to $397 in 2025. That places this record below the midpoint for pain medicine clinicians in ID, where the typical reported total is $4,838.
Across 29 payments — averaging $82.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Boston Scientific$659
- Vertex$122
- Pfizer$62
- Stimwave Technologies Incorporated$49
- Medtronic$41
- plus $68 from 4 others
What the payments were for
- Travel & lodging$1,24852%
- Food & beverage$1,15748%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 7 | $1,405 |
| Boston Scientific | 10 | $659 |
| Vertex | 1 | $122 |
| Pfizer | 3 | $62 |
| Stimwave Technologies Incorporated | 1 | $49 |
| Medtronic | 3 | $41 |
| Lilly USA, LLC | 1 | $21 |
| Arbor Pharmaceuticals, Inc. | 1 | $18 |
| Biodelivery Sciences International, Inc. | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$1,248
- Intracept$275
- JOURNAVX$122
- GENERAL PAIN MANAGEMENT$121
How this compares
$2,405 in reported general payments places this provider in the 30th percentile of 32 pain medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 108 | $118,019 |
| OxycontinOxycodone Hcl | 64 | $73,358 |
| RelistorMethylnaltrexone Bromide | 36 | $68,078 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,179 | $46,195 |
| Fentanyl | 167 | $34,266 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 90 | $27,764 |
| Oxycodone Hcl | 865 | $26,069 |
| Buprenorphine | 59 | $21,644 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 577 | $20,253 |
| Morphine Sulfate ErMorphine Sulfate | 573 | $18,558 |
| MovantikNaloxegol Oxalate | 39 | $16,947 |
| Gabapentin | 673 | $13,400 |
| Morphine Sulfate | 358 | $11,724 |
| Pregabalin | 377 | $11,130 |
| Modafinil | 38 | $9,105 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Boise
- Jason WilliamsBoise$177K
- Sandra ThompsonBoise$58K
- Christopher VaughanBoise$26K
- William BinegarBoise$5K
- Rebekah GuyBoise$3K
- Clinton MallariBoise$1K
- Slavik OsipchukBoise$146
- Richard DuboseBoise$20
- Jessica JamesonPost Falls$261K
- Daniel SmithIdaho Falls$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.